Ser78
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.1.1
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser78  -  STX4 (human)

Site Information
AtPLPEEsMkQELQN   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 1172732400

In vivo Characterization
Methods used to characterize site in vivo:
mutation of modification site ( 1 ) , western blotting ( 1 )
Disease tissue studied:
glioblastoma multiforme ( 1 ) , glioma ( 1 )
Relevant cell line - cell type - tissue:
U373 MG (glial) ( 1 )

Upstream Regulation
Treatments:
cGMP_analog ( 1 ) , KT5823 ( 1 )

Downstream Regulation
Effects of modification on STX4:
protein degradation ( 1 ) , ubiquitination ( 1 )

References 

1

Perrotta C, et al. (2018) Nitric Oxide Generated by Tumor-Associated Macrophages Is Responsible for Cancer Resistance to Cisplatin and Correlated With Syntaxin 4 and Acid Sphingomyelinase Inhibition. Front Immunol 9, 1186
29896202   Curated Info

Developed with grants from  NIH Logo and literature mining with Linguamatics  I2E Logo Creative Commons License PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

©2003-2019 Cell Signaling Technology, Inc.